Company Profile

Second Sight Medical Products Inc
Profile last edited on: 11/13/2023      CAGE: 49EK4      UEI: GY6VN2CMD1H3

Business Identifier: Implantable retinal prostheses for blind patients
Year Founded
1998
First Award
2007
Latest Award
2010
Program Status
Inactive
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

12744 San Fernando Road Building 3
Sylmar, CA 91342
   (818) 883-5000
   service@2-sight.com
   www.secondsight.com
Location: Multiple
Congr. District: 28
County: Los Angeles

Public Profile

Second Sight Medical Products, Inc. is organzied around development and provision of implantable visual prosthetics disgned to deliver artificial vision to blind individuals and to treat the population of sight-impaired individuals. The company offers the Orion Visual Cortical Prosthesis System, an implanted cortical stimulation device ntended to provide useful artificial vision to individuals who are blind due to various causes, including glaucoma, diabetic retinopathy, optic nerve injury or disease, and eye injury. The firm also offers Argus II Retinal Prosthesis System for treating retinitis pigmentosa.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
100-149
Revenue Range
10M-15M
VC funded?
Yes
Public/Private
Publicly Traded
Stock Info
NASDAQ : EYES
IP Holdings
250-500

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2010 1 NIH $2,988,224
Project Title: Development and Testing of Low Vision Assessment Tools for Retinal Prostheses
2008 2 NIH $459,172
Project Title: Hermetic Nanowire Interconnects for Neural Prostheses

Key People / Management

  Robert J Greenberg -- Former President and CEO, now Chairman of the Board of Directors

  Will Mcguire -- President And Ceo

  Gregoire Cosendai -- VP of European Operations

  Alfred E Mann -- Co-Founder, Chairman, Member of Audit Committee, Member of Compensation Committe

  Thomas B Miller -- Chief Financial Officer

  Anne-Marie Juliette Ripley -- VP of Clinical and Regulatory Affairs

  James D Weiland